Smart4Fabry is the acronym of a H2020 funded Project
that stands for “Smart functional GLA-nanoformulation
for Fabry disease”. Smart4Fabry is a collaborative project
funded under the H2020 EU Research
and Innovation programme.
The project started on
the 1st January 2017 and will last four years.
CONSORTIUM
NEWS
-
23.3.2021Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method
Fabry disease is a lysosomal storage disease arising from a deficiency of the enzyme α-ga...
-
15.2.2021Impact of Chemical Composition on the Nanostructure and Biological Activity of α Galactosidase Loaded Nanovesicles for Fabry Disease Treatment
Fabry disease is a rare lysosomal storage disorder characterized by a deficiency of α-gal...
-
2.11.2020Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine
A great chef could create an outstanding dish that revolutionizes cuisine – every time t...